Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

4.145 -0.145 (-3.38%)
Streaming Delayed Price Updated: 3:18 PM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CytomX Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
SOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity ↗
SoundHound AI stock is slipping on Thursday as SOUN investors appear unimpressed by a new LLM collaboration with Perplexity. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Dear NVDA Stock Fans, Mark Your Calendars for June 2 ↗
Nvidia stock fans will want to keep an eye on the tech company when June 2 rolls around for a potential catalyst for NVDA shares. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Is CytomX (CTMX) Stock Down 43% Today? ↗
CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update. 
Via InvestorPlace
News headline image
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
Via InvestorPlace
News headline image
CTMX Stock Earnings: CytomX Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗
CTMX stock results show that CytomX Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
Breaking on The Street Stocks To Watch Now! CTMX, PRSO, IMCC, KAVL, VTAK
Via AB Newswire
News headline image
Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday! 
Via InvestorPlace
News headline image
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates ↗
 
Via Benzinga
Topics Economy Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Crude Oil Down 3%; ISM Manufacturing PMI Falls In April ↗
 
Via Benzinga
News headline image
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally ↗
Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. 
Via InvestorPlace
Topics Cannabis
News headline image
What's Going On With CytomX Stock? ↗
CytomX Therapeutics shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8, after the close of... 
Via Benzinga
News headline image
Why Is CytomX (CTMX) Stock Up 180% Today? ↗
CytomX stock is rising higher on Wednesday as CTMX investors get an update on its upcoming earnings and clinical trial news. 
Via InvestorPlace
News headline image
US Stocks Mixed; Amazon Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. 
Via Benzinga
News headline image
Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today? ↗
Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin. 
Via InvestorPlace
News headline image
Why Is CytomX Therapeutics (CTMX) Stock Down 18% Today? ↗
CytomX Therapeutics stock is falling hard on Friday as CTMX shareholders appear unimpressed by its latest earnings report. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.